Oracle and NVIDIA are announcing a first-of-its-kind integration between NVIDIA accelerated computing and inference software with Oracle’s AI infrastructure and generative AI services, making over 160 AI tools and 100-plus NVIDIA NIM microservices available natively through the Oracle Cloud Infrastructure (OCI) console. This collaboration will accelerate the creation of agentic AI applications, merging the powers of NVIDIA and OCI to drive AI innovation.
By offering streamlined access to AI tools—including NVIDIA NIM, a set of 100-plus optimized, cloud-native inference microservices for leading AI models—through the OCI console, enterprises benefit from an integrated AI stack that adheres to the needs of modern enterprises.
“Oracle has become the platform of choice for both AI training and inferencing, and this partnership enhances our ability to help customers achieve greater innovation and business results,” said Safra Catz, CEO of Oracle. “NVIDIA’s offerings, paired with OCI’s flexibility, scalability, performance, and security, will speed AI adoption and help customers get more value from their data.”
“Oracle and NVIDIA are perfect partners for the age of reasoning—an AI and accelerated computing company working with a key player in processing much of the world’s enterprise data,” said Jensen Huang, founder and CEO of NVIDIA. “Together, we help enterprises innovate with agentic AI to deliver amazing things for their customers and partners.”
OCI’s 150-plus AI and cloud services will be deployable with NVIDIA accelerated computing and NVIDIA AI Enterprise in the data center, the public cloud, or at the edge. Additionally, OCI will be among the first cloud service providers to offer the next-gen NVIDIA Blackwell accelerated computing platform, delivering new NVIDIA GPU types across OCI’s public regions, government clouds, sovereign clouds, OCI Dedicated Region, Oracle Alloy, OCI Compute Cloud@Customer, and OCI Roving Edge Devices.
“The combination of OCI and NVIDIA delivers a full-stack AI solution, providing us the storage, compute, software tools, and support necessary to innovate faster with petabytes of data in developing our AI drug discovery platform,” said said Yerem Yeghiazarians, co-founder and CEO of Soley Therapeutics, a customer of NVIDIA and Oracle.
This announcement also unveils the companies’ collaboration on the no-code deployment of both Oracle and NVIDIA AI Blueprints, as well as an effort to accelerate AI vector search in Oracle Database 23ai with the NVIDIA cuVS library. These innovations aim to supercharge the development, deployment, and scale-out of AI applications for various use cases, according to the companies.
To learn more about NVIDIA and Oracle’s latest collaboration, please visit https://www.nvidia.com/en-us/ or https://www.oracle.com/.